Cochrane Abstracts
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First‐line Treatment of Advanced Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non‐squamous Non‐small Cell Lung Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435891/0/First‐line_treatment_of_advanced_epidermal_growth_factor_receptor__EGFR__mutation_positive_non‐squamous_non‐small_cell_lung_cancer.
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435891/0/First‐line_treatment_of_advanced_epidermal_growth_factor_receptor__EGFR__mutation_positive_non‐squamous_non‐small_cell_lung_cancer. Accessed December 6, 2024.
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435891/0/First‐line_treatment_of_advanced_epidermal_growth_factor_receptor__EGFR__mutation_positive_non‐squamous_non‐small_cell_lung_cancer
First‐line Treatment of Advanced Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non‐squamous Non‐small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435891/0/First‐line_treatment_of_advanced_epidermal_growth_factor_receptor__EGFR__mutation_positive_non‐squamous_non‐small_cell_lung_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
ID - 435891
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435891/0/First‐line_treatment_of_advanced_epidermal_growth_factor_receptor__EGFR__mutation_positive_non‐squamous_non‐small_cell_lung_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
